Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee

Farr, B M; Kaiser, D L; Harrison, B D; Connolly, C K
December 1989
Thorax;Dec1989, Vol. 44 Issue 12, p1031
Academic Journal
No abstract available.


Related Articles

  • Measurement of complement receptor 1 on neutrophils in bacterial and viral pneumonia. Hohenthal, Ulla; Nuutila, Jari; Lilius2, Esa-Matti; Laitinen, Iina; Nikoskelainen, Jukka; Kotilainen, Pirkko // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p11 

    Background: A reliable prediction of the causative agent of community-acquired pneumonia (CAP) is not possible based on clinical features. Our aim was to test, whether the measurement of the expression of complement receptors or Fcγ receptors on neutrophils and monocytes would be a useful...

  • Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Polverino, Eva; Torres, Antoni; Menendez, Rosario; Cillóniz, Catia; Valles, Jose Manuel; Capelastegui, Alberto; Marcos, M. Angeles; Alfageme, Inmaculada; Zalacain, Rafael; Almirall, Jordi; Molinos, Luis; Bello, Salvador; Rodríguez, Felipe; Blanquer, Josep; Dorado, Antonio; Llevat, Noelia; Rello, Jordi // Thorax;Nov2013, Vol. 68 Issue 11, p1007 

    Introduction Healthcare-associated pneumonia (HCAP) is actually considered a subgroup of hospital-acquired pneumonia due to the reported high risk of multidrug-resistant pathogens in the USA. Therefore, current American Thoracic Society/ Infectious Diseases Society of America guidelines suggest...

  • Bacteriological and clinical profile of Community acquired pneumonia in hospitalized patients. Shah, Bashir Ahmed; Singh, Gurmeet; Naik, Muzafar Ahmed; Dhobi, Ghulam Nabi // Lung India;Apr-Jun2010, Vol. 27 Issue 2, p54 

    The aim of our study was to obtain comprehensive insight into the bacteriological and clinical profile of community-acquired pneumonia requiring hospitalization. The patient population consisted of 100 patients admitted with the diagnosis of community-acquired pneumonia (CAP), as defined by...

  • A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Buising, K. L.; Thursky, K. A.; Black, J. F.; MacGregor, L.; Street, A. C.; Kennedy, M. P.; Brown, G. V. // Thorax;May2006, Vol. 61 Issue 5, p419 

    Background: Several severity scores have been proposed to predict patient outcome and to guide initial management of patients with community acquired pneumonia (CAP). Most have been derived as predictors of mortality. A study was undertaken to compare the predictive value of these tools using...

  • BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease.  // Thorax;Mar2008 Supplement 1, Vol. 63, pI1 

    The article presents the statement of the British Thoracic Society on criteria for respiratory care. It provides guidance on respiratory specialist clinic referral, follow-up and discharge as well as guidance on emergency admission and discharge to hospital. The guidance concerns the following...

  • Clinical features.  // Thorax;Dec2001 Supplement 4, Vol. 56, piv19 

    The article discusses the clinical features of community acquired pneumonia (CAP). Diagnosing pneumonia clinically without a chest radiograph is inaccurate, but the presence of normal vital signs on chest examination makes an underlying diagnosis of pneumonia unlikely. A review of published...

  • Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study. van de Garde, Ewoudt M. W.; Endeman, Henrik; van Hemert, Remco N.; Voorn, G Paul; Deneer, Vera H. M/; Leufkens, Hubert G. M.; van den Bosch, Jules M. M.; Biesma, Douwe H. // European Journal of Clinical Pharmacology;Apr2008, Vol. 64 Issue 4, p405 

    The causative micro-organism in community-acquired pneumonia (CAP) is often difficult to predict. Different studies have examined chronic morbidity and clinical symptoms as predictors for microbial aetiology of pneumonia. The aim of our study was to assess whether prior outpatient antimicrobial...

  • Inhaled Antibiotics for Hospital- Acquired and Ventilator- Associated Pneumonia. Daniels, Lindsay M.; Juliano, Jonathan; Marx, Ashley; Weber, David J. // Clinical Infectious Diseases;2/1/2017, Vol. 64 Issue 3, p386 

    A letter to the editor is presented in response to article "Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society" in the previous issue of the journal.

  • Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia. Kumagai, S.; Ishida, T.; Tachibana, H.; Ito, Y.; Ito, A.; Hashimoto, T. // European Journal of Clinical Microbiology & Infectious Diseases;Sep2015, Vol. 34 Issue 9, p1839 

    The aim of this study was to investigate the influence of bacterial coinfection on patients with pneumococcal pneumonia. We retrospectively analyzed the incidence, clinical features, microbial distributions, and outcomes of patients with bacterial coinfection in a cohort of 433 hospitalized...

  • Introduction and methods.  // Thorax;Dec2001 Supplement 4, Vol. 56, piv7 

    Community acquired pneumonia (CAP) is associated with significant morbidity, mortality and utilisation of health service resources. Recognising the clinical importance of CAP, numerous countries have developed national guidelines in the last decade, including Great Britain, the U.S., Canada,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics